News
-
Stillbirths steady
Thursday | May 31 2018WHILE Australia is one of the safest places in the world to give birth, close to 1% of babies are stillborn or die in the first month of life, according to a new Australian Institute of Health & Welfare report.
-
Dispensary Corner
Thursday | May 31 2018
31 May 18THE opioid crisis in the USA is reaching into the ocean, according to a new study by the Washington Department of Fish and Wildlife.
-
-
Consumer guide to cannabis
Wednesday | May 30 2018THE TGA has released a new patient information document on medicinal cannabis, noting that there is "limited evidence on its success in treating different medical conditions, or on effective forms and dosages".
-
Pharmacy Alliance Aussie push
Wednesday | May 30 2018PHARMACY Alliance yesterday launched an initiative aiming to showcase emerging Australian products to Chinese 'Daigou' buyers via its network of more than 650 independently owned pharmacies.
-
TWC & DB take it to heart
Wednesday | May 30 2018TERRYWHITE Chemmart and DB Cosmetics have partnered together to create two lipstick shades, with $3 from every sale being donated directly to The Heart Foundation.
-
Pregnancy CM response
Wednesday | May 30 2018THE Australian Self-Medication Industry (ASMI) has reminded consumers that pregnant women should always check with a healthcare professional before taking any medicine, including supplements and vitamins.
-
Ego QV eczema launch
Wednesday | May 30 2018EGO Pharmaceuticals has announced the development of a new intensive moisturising product range "clinically proven to help prevent dryness and help skin maintain optimal hydration levels".
-
Simponi PBS funded
Wednesday | May 30 2018THE estimated 33,000 Australians living with moderately to severely active ulcerative colitis (UC) will be pleased to learn that Federal Health Minister Greg Hunt has announced the PBS funding of Janssen's Simponi (golimumab) under certain eligibility criteria, effective 01 Jun.
-
Wilson Alexion deal on
Wednesday | May 30 2018US-LISTED biopharma-company Alexion has announced 97.7% of Wilson Therapeutics shareholders have accepted its offer to acquire the rare liver-disorder (Wilson Disease) therapy company.
